Tagrisso 80 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FC7FM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,237
Award facts
- Contract value 100% obligated
- $11,236.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 mg tablets (30-count units) valued at $11,236.71 under a firm fixed-price contract awarded on December 30, 2025, with completion scheduled for January 22, 2026. This is a non-set-aside competitive award to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026, which enables the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates proven capability to deliver diverse pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This particular delivery order for TAGRISSO—an oncology medication used in cancer treatment—represents a routine procurement from the contractor's established relationship with DLA's pharmaceutical supply chain, consistent with the company's demonstrated track record of fulfilling federal medical supply requirements through competitive contracting processes.
Quick answers
Who was awarded contract SPE2DR26FC7FM?
SPE2DR26FC7FM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FC7FM worth?
The government has obligated $11,237 on SPE2DR26FC7FM.
Is contract SPE2DR26FC7FM an order under another contract?
Yes. SPE2DR26FC7FM is a delivery order under SPE2DR25D2217, an indefinite delivery contract.
Was contract SPE2DR26FC7FM competed?
The extent of competition for SPE2DR26FC7FM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award